ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

10816	Companies
234390	Keywords
163217	Articles
125370	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 05/22/2026 at 22:05, 2 months 18 days ago

Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Abivax reports Q1 2026 financial results and interim data from UC Study 108, showing strong clinical remission with obefazimod. Cash position at €491.6M. Updates on upcoming trials and financial highlights

Financial Results Abivax Obefazimod Clinical Trials UC Study 108
BRIEF

published on 05/11/2026 at 22:10, 2 months 29 days ago

Abivax: Results of the 2026 Annual General Meeting

Biotechnology Abivax Resolutions General Assembly Immune Response
BRIEF

published on 05/11/2026 at 22:10, 2 months 29 days ago

Abivax Reports Outcomes of Annual General Meeting

Shareholders Abivax Ulcerative Colitis Annual Meeting Resolutions
PRESS RELEASE

published on 05/11/2026 at 22:05, 2 months 29 days ago

Abivax Announces Results of its May 11, 2026 Annual General Meeting
Abivax announces results of its annual general meeting for 2026, including resolutions adopted and details on financial statements and compensation policy

Annual General Meeting Shareholders Financial Statements Biotechnology Abivax
BRIEF

published on 05/05/2026 at 08:05, 3 months 5 days ago

Abivax Reacquires Royalty Certificates and Proceeds with $45M ADS Offering

Abivax Financial Strategy Royalty Certificates ADS Offering Dilution Impact
PRESS RELEASE

published on 05/05/2026 at 08:00, 3 months 5 days ago

Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares
Abivax announces repurchase of royalty certificates and pricing of $45M (€38.5M) offering of American Depositary Shares to strengthen balance sheet and enhance shareholder value

Abivax Repurchase American Depositary Shares Royalty Certificates $45M Offering
BRIEF

published on 04/27/2026 at 18:05, 3 months 12 days ago

ABIVAX: Composition of share capital and voting rights

Euronext Paris Share Capital Voting Rights Abivax Number Of Shares
BRIEF

published on 04/22/2026 at 22:10, 3 months 17 days ago

Abivax unveils key data on obefazimod at Digestive Disease Week

Abivax Obefazimod Ulcerative Colitis Clinical Trials Digestive Disease Week
BRIEF

published on 04/22/2026 at 22:10, 3 months 17 days ago

Abivax to Present Data on Obefazimod at Digestive Disease Week®

Abivax Obefazimod Ulcerative Colitis Phase 3 Clinical Trials DDW 2026
PRESS RELEASE

published on 04/22/2026 at 22:05, 3 months 17 days ago

Abivax to Present Data on Obefazimod at Digestive Disease Week®
Abivax to present data on Obefazimod at Digestive Disease Week, showcasing efficacy, safety, and patient outcomes from Phase 3 ABTECT program and preclinical anti-fibrotic models

Abivax Obefazimod Clinical Trials Digestive Disease Week Inflammatory Bowel Disease

Accesswire

Published on 08/10/2026 at 15:30, 1 hour 9 minutes ago

Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 1 hour 14 minutes ago

Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 2 hours 9 minutes ago

NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 3 hours 9 minutes ago

Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 13:00, 3 hours 39 minutes ago

Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada

View all ACCESSWIRE

EQS Group

Published on 08/10/2026 at 16:12, 26 minutes ago

dK Calls on PANDION AG Bondholders to Join Forces
Published on 08/10/2026 at 15:56, 42 minutes ago

Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets
Published on 08/10/2026 at 15:46, 52 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/10/2026 at 15:44, 54 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 08/10/2026 at 15:43, 55 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc

Les Echos

Published on 08/10/2026 at 11:53, 4 hours 45 minutes ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 5 hours 2 minutes ago

GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 7 hours 16 minutes ago

Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 07:00, 9 hours 39 minutes ago

BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/07/2026 at 18:54, 2 days 21 hours ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026

View all LES ECHOS COMFI WIRE